Production planning and control (PPC) systems that employ aspects from both make-to-order (MTO) and make-to-stock (MTS) production control are known as hybrid MTS/MTO systems. While both MTO and MTS separately have been studied extensively, their combined use has received less attention. However, the literature on this topic is growing and this paper shows that the review performed in this paper is an important addition to the field. We categorise relevant literature according to a novel taxonomy and show that hybrid MTS/MTO production control can be used in different contexts. In addition, an overview of the modelling techniques and methods used in these papers is provided. Based on the reviewed literature, relevant research questions and directions for future research are identified. Finally, it is shown that hybrid MTS/MTO production control is prevalent in practice by discussing research with industrial applications. The paper contains an overview of research on hybrid MTS/MTO production control to be used as reference for researchers active in the field, and provides managerial insights and directions for future research on this topic.
In this paper, we study a production system that operates under a leadtime performance constraint which guarantees the completion of an order before a pre-determined lead-time with a certain probability. The demand arrival times and the service requirements for the orders are random. To reduce the capacity-related operational costs, the production system under study has the option to use flexible capacity. We focus on periodic capacity policies and model the production system as a queuing system that can change its capacity periodically and choose to operate in one of the two levels: a permanent capacity level and a permanent plus contingent capacity level. Contingent capacity is supplied if needed at the start of a period, and is available during that period, at a cost rate that is decreasing in period length in different functional forms. Next, we propose a search algorithm that finds the capacity levels and the switching point that minimizes the capacity-related costs for a given period length. The behaviour of the capacity-related costs changes drastically under different period lengths and cost structures. In our computational study, we observe that the periodic capacity flexibility can reduce the capacity-related operational costs significantly (up to 35%). However, in order to achieve these savings, the period length must be chosen carefully depending on ambition level and capacity-related costs. We also observe that the percentage savings are higher for more ambitious lead-time performance constraints. Moreover, we observe that the use of contingent capacity makes the total system costs more insensitive to the lead-time performance requirements.
published version features the final layout of the paper including the volume, issue and page numbers.
Link to publication
General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.